Robert L Keith MD
Critical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Colorado School of Medicine
Join to View Full Profile
1055 Clermont St# 111ADenver, CO 80220
Phone+1 303-393-2869
Fax+1 303-393-4639
Dr. Keith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
University of WashingtonResidency, Internal Medicine, 1993 - 1996- University of Colorado School of Medicine Anschutz Medical CampusClass of 1993
Certifications & Licensure
CO State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease Start of enrollment: 2001 Nov 01
- Pioglitazone for Lung Cancer Chemoprevention Start of enrollment: 2009 Aug 01
- Transition From Hospital to Home Post Cardiac Condition Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 267 citationsLung adenocarcinoma promotion by air pollutants.William Hill, Emilia L Lim, Clare E Weeden, Claudia Lee, Marcellus Augustine
Nature. 2023-04-01 - 1 citationsProtocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model.Lori Dwyer-Nield, Robert L Keith, Meredith A Tennis
STAR Protocols. 2022-12-16 - 7 citationsPPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.Lori D Dwyer-Nield, Debbie G McArthur, Tyler M Hudish, Laura I Hudish, Carol Mirita
International Journal of Cancer. 2022-12-15
Journal Articles
- Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer ChemopreventionRobert Keith, MD, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
